Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 60 years old or older
- You have type 2 diabetes with blood sugar levels that are not well controlled (based on a specific blood test result, called HbA1c, falling between 7.1% and 10%)
- You are of Chinese ethnicity
- You have sleeping problems (insomnia), based on a score above 10 on a standard sleep questionnaire
- You are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- You have significant memory or thinking difficulties, based on a cognitive test score (confirm with trial site)
- You have depression (based on a questionnaire score above 8) or other mental health conditions such as generalized anxiety disorder, restless leg syndrome, or schizophrenia
- You have an enlarged prostate or any other long-term condition likely to affect sleep, such as chronic pain
- You are currently taking sleeping pills, psychiatric medications, or any other drugs known to affect sleep
- You have had a stroke, vascular dementia, or any other condition known to affect brain and thinking function
- You work shift patterns (non-standard working hours)
- You have certain blood or kidney conditions that would affect the accuracy of the blood sugar test used in this trial (confirm with trial site)
- The trial investigators decide, for any other reason, that participation would not be suitable for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 3505 2648
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The primary outcome measure will be changes in glycemic control, as measured by HbA1c, from baseline.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.